Harrigan Edmund reported option exercise involving 8,107 derivative units of ACADIA PHARMACEUTICALS INC at $0.00 for $0 on May 29, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Jun 1, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
8,107Restricted Stock Units
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
May 29, 2026Option exercise
Filed
Jun 1, 2026, 6:00 PM ET3-day reporting delay
Accession
0001177917-26-000009Code M · Transaction 388045
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 29, 2026Grant9,311$0.00$0Trade 388047
May 29, 2026Grant16,004$0.00$0Trade 388046
May 29, 2026Option exercise8,107——Trade 388044
4 transaction rows in this filing. Joint filers share the same rows.

ACAD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ACAD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +3.2%1w ago −2%1d ago +0.5%
Returns since7d +0.8%30d +17%90d +35%180d1y

Footnotes in full

F1: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2: The restricted stock units vested in full on May 29, 2026, the date on which an annual meeting of stockholders was held. F3: The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders. F4: The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders.